Scholarlink

<p>We prepared curcumin (Cur)/carboxymethyl-<i>β</i>-cyclodextrin (CM-<i>β</i>-CD) complex by grinding method. According to the characteristics of the tumor microenvironment, a pH-responsive nanogel loaded with Cur was designed and prepared (by CM-<i>β</i>-CD and chitosan) and consequently characterized by DLS, TEM, FTIR, <sup>1</sup>H NMR, SEM, <i>etc. In vitro</i> release results show that Cur-loaded Chitosan-CM-<i>β</i>-CD nanogel (Cur-CS-CM-<i>β</i>-CD) released Cur rapidly under acidic conditions, and its cumulative release rate is 41%, 56% and 67% at pH 7.4, 6.5 and 5.5, respectively. The cell inhibition rate of Cur-CS-CM-<i>β</i>-CD on MCF-7 cell lines was detected by the MTT assay. The results suggest the cell inhibition rate of Cur-CS-CM-<i>β</i>-CD is (50.2±2.5)% at 10 µM, (98.3±1.2)% at 40 µM and (97.5±1.2)% at 80 µM, respectively. It is revealed that the pH-responsive nanogel loaded Cur can effectively inhibit the growth of breast cancer cells and has the potential for clinical application.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anti-breast Cancer Activity of pH-responsive Nanogel Loaded with Curcumin

  • 期刊论文

  • 发表日期：

    2025年5月17日

查看全文
  • Ruipeng Shang,
  • Yuxin Wang,
  • Xinqi Wang,
  • Zigui Wang,
  • Lili Duan,
  • Xuejie Qi

摘要

We prepared curcumin (Cur)/carboxymethyl-β-cyclodextrin (CM-β-CD) complex by grinding method. According to the characteristics of the tumor microenvironment, a pH-responsive nanogel loaded with Cur was designed and prepared (by CM-β-CD and chitosan) and consequently characterized by DLS, TEM, FTIR, 1H NMR, SEM, etc. In vitro release results show that Cur-loaded Chitosan-CM-β-CD nanogel (Cur-CS-CM-β-CD) released Cur rapidly under acidic conditions, and its cumulative release rate is 41%, 56% and 67% at pH 7.4, 6.5 and 5.5, respectively. The cell inhibition rate of Cur-CS-CM-β-CD on MCF-7 cell lines was detected by the MTT assay. The results suggest the cell inhibition rate of Cur-CS-CM-β-CD is (50.2±2.5)% at 10 µM, (98.3±1.2)% at 40 µM and (97.5±1.2)% at 80 µM, respectively. It is revealed that the pH-responsive nanogel loaded Cur can effectively inhibit the growth of breast cancer cells and has the potential for clinical application.